SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0000950123-05-007504
Filing Date
2005-06-17
Accepted
2005-06-17 17:16:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A y09827a1sctoviza.htm SC TO-I/A 47649
2 EX-99.A.1.B: LETTER OF TRANSMITTAL y09827a1exv99waw1wb.htm EX-99.A.1.B 127240
3 EX-99.A.1.C: NOTICE OF GUARANTEED DELIVERY y09827a1exv99waw1wc.htm EX-99.A.1.C 27167
4 EX-99.A.1.F: LETTER TO CLIENTS FOR USE BY BROKERS, DEALERS, BANKS, TRUST COMPANI y09827a1exv99waw1wf.htm EX-99.A.1.F 31623
5 EX-99.A.1.G: FORM OF LETTER FROM MYLAN LABORATORIES INC. TO PARTICIPANTS IN ITS y09827a1exv99waw1wg.htm EX-99.A.1.G 27779
6 GRAPHIC y09827a1y0982702.gif GRAPHIC 1946
  Complete submission text file 0000950123-05-007504.txt   266481
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Filed by) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Subject) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: SC TO-I/A | Act: 34 | File No.: 005-10728 | Film No.: 05903849
SIC: 2834 Pharmaceutical Preparations